BioExx Announces Management Change
News Aug 09, 2011
BioExx Specialty Proteins Ltd. has announced that Chris Carl has resigned as Chairman and Chief Executive Officer of BioExx.
The Company's Chief Financial Officer, Chris Schnarr, has been appointed interim CEO, effective immediately.
The Board of Directors will commence a search and hiring process for a permanent CEO, reflective of the needs of the Company as it moves forward with the execution of its business plan and to renew and ensure continued value creation for shareholders.
The Board and Mr Carl have agreed that a change in leadership would be healthy for the Company at this time.
Given the current annual plant shutdown in Saskatoon for maintenance and capital projects, as well as the recent commencement of protein production operations and the consequently transitioning needs of the business going forward, it was agreed that now was the appropriate time for such a change.
Accordingly, the Board has agreed to accept the resignation of Mr Carl.
William Ollerhead, a member of the Company's Audit Committee and Chair of the Corporate Governance and Compensation Committee, has been elected by the Company's directors as Chairman of the Board.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
2019 Environmental Science and Climate Change Conference
Sep 10 - Sep 11, 2019
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019